# Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19

> **NCT04338360** · — · APPROVED_FOR_MARKETING · sponsor: **Mayo Clinic**

## Conditions studied

- COVID19

## Interventions

- **BIOLOGICAL:** COVID-19 convalescent plasma

## Key facts

- **NCT ID:** NCT04338360
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338360, "Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04338360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*